RARE DISEASES A–Z · LETTER R
Rett Syndrome
Rett syndrome is a genetic neurological condition that affects brain development, almost exclusively in girls. After a period of apparently normal infancy, development reverses — a regression that is devastating for families — before stabilising into a long plateau with profound disability but also real capacity for connection.
By Dr. Mohamed Ibrahim, MD, PhD — Assistant Professor of Medicine, Transplant Nephrology, University of Maryland School of Medicine · Last reviewed: November 2026
Rare Diseases A–Z is part of the MedicalVideos.com education program. It is produced independently of sponsors, and any future sponsorship will be labelled on the hub.
The guide
The basics
MECP2 makes a protein that regulates the activity of many other genes in the brain; nerve cells need it in the right amount — too little causes Rett syndrome, and too much causes a related disorder. Girls with the classic form develop apparently normally for the first 6 to 18 months, then regress: head growth slows, spoken words are lost, and purposeful hand use disappears, replaced by constant hand-wringing, clapping, or mouthing movements. Social engagement often withdraws during regression, then partly returns — eye contact and eye-pointing become powerful communication tools. Later features include epilepsy, breathing abnormalities (episodes of hyperventilation and breath-holding while awake), scoliosis, small cold hands and feet, teeth grinding, sleep disturbance, and anxiety. Severity varies with the exact mutation and X-inactivation pattern.
How it works
Diagnosis is clinical — the consensus criteria require the characteristic regression and features — confirmed by MECP2 genetic testing, which finds the cause in the great majority of classic cases. A minority have variants in related genes (CDKL5, FOXG1) causing early-onset forms now classified separately. Assessment maps epilepsy, breathing pattern, spine, nutrition and growth, bone health, heart rhythm (a prolonged QT interval is associated), and communication ability. Because presentation overlaps with autism and cerebral palsy, Rett syndrome is worth considering in any girl with developmental regression — genetic testing settles it and connects families to specific support and trials.
Day to day
The first Rett-specific medicine (trofinetide, a daily oral solution) is now approved in some countries and produces modest improvements in symptom scores; it is symptomatic, not curative. Beyond it, care is expert supportive management: seizure medicines chosen for the individual's epilepsy; physiotherapy and hydrotherapy to maintain mobility and slow scoliosis; orthotics and seating; nutritional support; and communication therapy built around eye gaze — many people with Rett syndrome understand far more than they can show without the right tools. Gene therapy trials (delivering a regulated copy of MECP2) are in early clinical testing and are the field's great hope. Life expectancy has improved with modern care, with many women living into their 40s, 50s, and beyond.
When to get help
Care is coordinated by paediatric neurology and later adult services with experience of complex disability: epilepsy management, physiotherapy, scoliosis surveillance and surgery when needed, nutrition (gastrostomy when swallowing or intake fails), bone health, and communication technology assessment. Breathing abnormalities are usually managed by awareness rather than intervention, but sleep studies help when apnoea is suspected. Report seizures that change pattern, choking, chest infections, or rapid spine progression. Transition planning to adult services is a known weak point — start early. Rett syndrome organisations maintain clinician networks and research registries that families should know about.
Common questions
Why does Rett syndrome almost only affect girls?
Because MECP2 sits on the X chromosome. Boys with a full mutation usually lack a second copy to compensate and are severely affected from birth, often not surviving infancy — though boys with mosaicism or an extra X chromosome can have classic Rett syndrome. Girls' second X provides enough working cells for survival with the Rett pattern.
Is there a specific medicine for Rett syndrome?
Trofinetide — a medicine modelled on a growth-factor fragment — was the first treatment approved specifically for Rett syndrome (in the US, for ages two and up), improving a combined measure of symptoms and clinician impression in trials. It is a symptomatic advance, not a cure; gene therapy trials aiming at the root cause are under way.
Does the regression keep going?
The regression usually occurs between 12 and 30 months: speech and hand use are lost, hand stereotypies appear, and growth of head size slows. Skills are not usually lost further after this stage — the condition stabilises into a plateau phase that can last decades, and some abilities (especially eye-based communication) can improve with support.
Can people with Rett syndrome communicate?
Yes — eye gaze is the most reliable channel. Many people with Rett syndrome communicate choices, preferences, and humour with eye-pointing boards and eye-gaze technology, and families consistently say understanding far exceeds what speech-based testing suggests. Presuming competence is the right default.
More in Letter R
Related
Sources
- Rett Syndrome (MedlinePlus)
- Rett Syndrome — MedlinePlus Genetics (MedlinePlus)
- Rett Syndrome (National Organization for Rare Disorders (NORD))
- Rett Syndrome — Genetic and Rare Diseases Information Center (NIH GARD)
This guide is general information, not medical advice. Rare diseases are individual — diagnosis and treatment depend on your own results, other conditions, and treatment history, and are set by your treating team. Never start, stop, or change a medicine because of something you read here. If you have severe breathlessness, uncontrolled bleeding, confusion, sudden weakness, or thoughts of harming yourself, seek urgent care. Seizure, breathing, and scoliosis care are individual; follow your specialist team's plan.